Intensified Hyposensitization Is an Effective Treatment of Postorgasmic Illness Syndrome (POIS)

Sex Med. 2022 Apr;10(2):100474. doi: 10.1016/j.esxm.2021.100474. Epub 2022 Jan 15.

Abstract

Introduction: Postorgasmic illness syndrome (POIS) is an extremely rare urogenital disease which significantly and negatively impacts the functioning and sexual activity.

Aims: A 34-year-old male presented with POIS symptoms and confirmed the allergic component of the POIS. Intensified immunotherapy with autologous semen was recommended.

Methods: The treatment lasted 14 months and included 20 visits. Modified and intensified subcutaneous immunotherapy in both forearms significantly shortened the therapy and improved the outcome, with high-tolerance and no adverse effects or hyperactive responses.

Main outcome measure: Improvement in POIS symptoms through the use of intensified immunotherapy with autologous semen.

Results: The improvement was significant enough to allow for higher sexual activity, and gradual resumption of private and professional activity.

Conclusion: Intensified immunotherapy with autologous semen seems an effective and safe option for treating patients with suspected immune-allergenic POIS. To the best of our knowledge, this has been the first such intensive and effective allergen-specific immunotherapy of POIS. Wrotynska-Barczynska J, Swat. Swat E, Berger A, et al. Intensified Hyposensitization Is an Effective Treatment of Postorgasmic Illness Syndrome (POIS). Sex Med 2022;10:100474.

Keywords: Immunotherapy With Autologous Semen; Intensified Immunotherapy; POIS; Postorgasmic Illness Syndrome.

Publication types

  • Case Reports